Skip to main content
SpringerLink
Log in

Status of a group BNeisseria meningitidis vaccine

  • Editorial
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Peltola, H., Makela, P. H., Kaythy, H., Jousimies, H., Herva, E., Halstrom, K., Sivonen, A., Renkonen, O. V., Pettay, O., Kranko, V., Ahonen, P., Sarna, S.: Clinical efficacy of meningococcus group A capsular poly-saccharide vaccine in children three months to five years of age. New England Journal of Medicine 1977, 297: 686–691.

    PubMed  Google Scholar 

  2. Peltola, H.: Meningococcal disease: still with us. Reviews of Infectious Diseases 1983, 5: 71–91.

    PubMed  Google Scholar 

  3. Hankins, W. A., Gwaltney, J. M., Hendley, J. O., Farquhar, J. D., Samuelson, J. S.: Clinical and serological evaluation of a meningococcal polysaccharide vaccine, groups A, C, Y, and W135. Proceedings of the Society for Experimental Biology and Medicine 1982, 169: 54–57.

    PubMed  Google Scholar 

  4. Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., Berman, S. L., Lowenthal, J. P.: Immunologic response of man to group B polysaccharide vaccines. Journal of Infectious Diseases 1972, 126: 514–522.

    PubMed  Google Scholar 

  5. Jennings, H. J., Lugowski, C.: Immunochemistry of groups A, B, and C menigococcal polysaccharidetetanus toxoid conjugates. Journal of Immunology 1982, 127: 1011–1018.

    Google Scholar 

  6. Finne, J., Leinonen, M., Makela, P. H.: Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet 1983, ii: 355–357.

    Google Scholar 

  7. Zollinger, W. D., Boslego, J. E., Frasch, C. E., Froholm, L. O.: Safety of vaccines containing meningococcal group B polysaccharide. Lancet 1984, ii: 166–167.

    Google Scholar 

  8. Tettmer, R. E., Abbott, J. D., Jones, D. M.: Meningococcal meningitis in Royal Air Force recruits. Public Health 1977, 91: 253–275.

    PubMed  Google Scholar 

  9. Frasch, C. E., Peppler, M. S.: Protection against group BNeisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens. Infections and Immunity 1982, 37: 271–280.

    Google Scholar 

  10. Zollinger, W. D., Mandrell, R. E., Griffiss, J. M., Altieri, P., Berman, S.: Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. Journal of Clinical Investigation 1979, 63: 836–848.

    PubMed  Google Scholar 

  11. Frasch, C. E., Zollinger, W. D., Poolman, J. T.: Serotype antigens ofNeisseria meningitidis and a proposed scheme for designation of serotypes. Reviews of Infectious Diseases 1985, 7: 504–510.

    PubMed  Google Scholar 

  12. Frasch, C. E.: Noncapsular surface antigens ofNeisseria meningitidis. In: Weinstein, L., Fields, B. N. (ed.): Seminars in infectious disease. Volume 2. Stratton, New York, 1979, p. 304–337.

    Google Scholar 

  13. Salit, I. E., Tomalty, L.: Experimental meningococcal infection in neonatal mice: differences in virulence between strains isolated from human cases and carríers. Canadian Journal of Microbiology 1984, 30: 1042–1045.

    PubMed  Google Scholar 

  14. Holten, E.: Serotypes ofNeisseria meningitidis isolated from patients in Norway during the first six months of 1978. Journal of Clinical Microbiology 1979, 9: 186–188.

    PubMed  Google Scholar 

  15. Mocca, L. F., DelReal, G., Frasch, C. E.: Serotypes and polyacrylamide gel electrophoresis types among group BNeisseria meningitidis disease isolates in Spain (1976–1979). Journal of Infectious Diseases 1983, 148: 249–253.

    PubMed  Google Scholar 

  16. Peppier, M. S., Frasch, C. E.: Protection against group BNeisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype 2 protein preparations. Infection and Immunity 1982, 37: 264–270.

    PubMed  Google Scholar 

  17. Craven, D. E., Frasch, C. E.: Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse model. Infection and Immunity 1979, 26: 110–117.

    PubMed  Google Scholar 

  18. Frasch, C. E., Robbins, J. D.: Protection against group B meningococcal disease. III: immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. Journal of Experimental Medicine 1978, 147: 629–644.

    PubMed  Google Scholar 

  19. Zollinger, W. D., Mandrell, R. E., Altieri, P., Berman, J., Lowenthal, J., Artenstein, M. S.: Safety and immunogenicity of a meningococcal type 2 protein vaccine in animal and human volunteers. Journal of Infectious Diseases 1978, 137: 728–739.

    PubMed  Google Scholar 

  20. Skevakis, L., Frasch, C. E., Zahradnik, J. M., Dolin, R.: Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens ofNeisseria meningitidis. Journal of Infectious Diseases 1984, 149: 387–396.

    PubMed  Google Scholar 

  21. Zollinger, W. D., Mandrell, R. E., Griffiss, J. M.: Enhancement of immunologic activity by noncovalent complexing of meningococcal group B polysaccharide and outer membrane proteins. In: Robbings, J. R., Hill, J. C., Sadoff, J. C. (ed.): Seminars in infectious diseases. Volume 4. Thieme-Stratton, New York, 1982, p. 254–262.

    Google Scholar 

  22. Frasch, C. E.: Immunization againstNeisseria meningitidis. In: Easmon, C. S. F., Jeljaszewicz, J. (ed.): Medical microbiology. Volume 2. Academic Press, New York, 1983, p. 115–144.

    Google Scholar 

  23. Frasch, C. E., Coetzee, G., Zahradnik, J. M., Feldman, H. A., Koornhof, H. J.: Development and evaluation of group B serotype 2 protein vaccines: report of a group B field trial. Medecine Tropicale 1983, 43: 177–180.

    PubMed  Google Scholar 

  24. Coetzee, G. J., Frasch, C. E., Mocca, L. F.: Longitudinal studies of meningococcal carriage during a group B epidemic. Medicine Tropicale 1983, 43: 43–46.

    Google Scholar 

  25. Wang, L. Y., Frasch, C. E.: Development of aNeisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model. Infection and Immunity 1984, 46: 408–414.

    PubMed  Google Scholar 

  26. Zollinger, W. D., Mandrell, R. E.: Studies of the human antibody response to specific meningococcal outer membrane proteins of serotypes 2 and 15. Médicine Tropicale 1983, 43: 143–147.

    Google Scholar 

  27. Zollinger, W. D., Moran, E. E., Connelly, H., Mandrell, R. E., Brandt, B.: Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins ofNeisseria meningitidis and their use in serotyping. Infection and Immunity 1984, 46: 260–266.

    PubMed  Google Scholar 

  28. Jennings, H. J., Lugowski, C., Ashton, F. E.: Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group BNeisseria meningitidis. Infection and Immunity 1984, 43: 407–412.

    PubMed  Google Scholar 

  29. Cannon, J. G., Black, W. J., Nachamkin, I., Stewart, P. W.: Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenicNeisseria species. Infection and Immunity 1984, 43: 994–999.

    PubMed  Google Scholar 

  30. West, S. E. H., Sparling, P. F.: Response ofNeisseria gonorrohoeae to iron limitation: alteration in expression of membrane proteins without apparent siderophore production. Infection and Immunity 1985, 47: 388–394.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Office of Biologies, Center for Drugs and Biologies, Food and Drug Administration, 20892, Bethesda, Maryland, USA

    C. E. Frasch

Authors
  1. C. E. Frasch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frasch, C.E. Status of a group BNeisseria meningitidis vaccine. Eur. J, Clin. Microbiol. 4, 533–536 (1985). https://doi.org/10.1007/BF02013388

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013388

Search

Navigation